» Authors » Vincent Flacher

Vincent Flacher

Explore the profile of Vincent Flacher including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 36
Citations 677
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Arbogast F, Sal-Carro R, Boufenghour W, Frenger Q, Bouis D, Filippi De La Palavesa L, et al.
J Cell Biol . 2024 Nov; 224(2). PMID: 39535446
Macroautophagy (often-named autophagy), a catabolic process involving autophagy-related (Atg) genes, prevents the accumulation of harmful cytoplasmic components and mobilizes energy reserves in long-lived and self-renewing cells. Autophagy deficiency affects antigen...
2.
Goreski H, Ilic D, Flacher V, van den Bogaard E, Guttmann-Gruber C, Tanaka R, et al.
J Invest Dermatol . 2024 Sep; 145(1):15-17. PMID: 39230535
No abstract available.
3.
Chneiweiss H, Dubart-Kupperschmitt A, Duclos-Vallee J, Clement B, Flacher V, Galzi J, et al.
Med Sci (Paris) . 2023 Nov; 39(11):876-878. PMID: 38018932
No abstract available.
4.
Sponsel J, Guo Y, Hamzam L, Lavanant A, Perez-Riveron A, Partiot E, et al.
EMBO Rep . 2023 Mar; 24(4):e55971. PMID: 36856136
Pseudomonas aeruginosa is a Gram-negative bacterium causing morbidity and mortality in immuno-compromised humans. It produces a lectin, LecB, that is considered a major virulence factor, however, its impact on the...
5.
Pierrevelcin M, Flacher V, Mueller C, Vauchelles R, Guerin E, Lhermitte B, et al.
Adv Healthc Mater . 2022 Sep; 11(19):e2200195. PMID: 36057996
Osteosarcoma (OS) is the most common primary bone cancer, where the overall 5-year surviving rate is below 20% in resistant forms. Accelerating cures for those poor outcome patients remains a...
6.
Tricarico P, Moltrasio C, Gradisek A, Marzano A, Flacher V, Boufenghour W, et al.
Sci Rep . 2022 May; 12(1):8415. PMID: 35589750
Hidradenitis suppurativa (HS) is a recurrent inflammatory skin disease with a complex etiopathogenesis whose treatment poses a challenge in the clinical practice. Here, we present a novel integrated pipeline produced...
7.
Brulefert A, Kraemer M, Cumin M, Selle A, Hoste A, Gad H, et al.
J Invest Dermatol . 2021 Jun; 141(12):2985-2989.e5. PMID: 34119485
No abstract available.
8.
Muller Q, Berthod F, Flacher V
Med Sci (Paris) . 2021 Jan; 37(1):68-76. PMID: 33492221
The immune system and the sensory nervous system are responsible for perceiving danger under distinct yet complementary forms. In the last few years, neuroimmune interactions have become an important topic...
9.
Brulefert A, Hoste A, Muller Q, Fauny J, Mueller C, Flacher V
Allergy . 2020 Dec; 76(7):2044-2056. PMID: 33368331
Background: Immune modulation by vitamin D3 through dendritic cells (DCs) remains controversial. Human DCs exposed in vitro counteract type-1 T-helper (Th1) differentiation and induce regulatory T cells. However, cutaneous application...
10.
Mueller C, Camara A, Flacher V
Med Sci (Paris) . 2020 Oct; 36(10):835-838. PMID: 33026320
No abstract available.